Renovos Biologics strengthens its Board’s US expertise with the appointment of Lisa Ferrara, Ph.D., as a Non-Executive Director
— Lisa Ferrara, Ph.D., brings over 30 years of experience in orthopaedic medical device innovation and regulatory strategy in the USA — Dr Ferrara will play a pivotal role in advancing Renovos’ lead product RENOVITE® BMP-2 through FDA regulatory approval in the USA — RENOVITE® is a synthetic, biodegradable nanoclay carrier that is a novel […]